Sep 2007
A Critical Assessment of the Performance of Protein-Ligand Scoring Functions Based on NMR Chemical Shift Perturbations
September 15, 2007 Filed In:NMR
Abstract: We have generated docking
poses for the FKBP-GPI complex using eight docking
programs, and compared their scoring functions with
scoring based on NMR chemical shift perturbations
(NMRScore). Because the chemical shift perturbation
(CSP) is exquisitely sensitive on the orientation of
the ligand inside the binding pocket, NMRScore offers
an accurate and straightforward approach to score
different poses. All scoring functions were inspected
by their abilities to highly rank the native-like
structures and separate them from decoy poses
generated for a protein-ligand complex. The overall
performance of NMRScore is much better than that of
energy-based scoring functions associated with
docking programs in both aspects. In summary, we find
that the combination of docking programs with
NMRScore results in an approach that can robustly
determine the binding site structure for a
protein-ligand complex, thereby providing a new tool
facilitating the structure-based drug discovery
process.
Authors: Bing Wang, Lance M. Westerhoff, and Kenneth M. Merz Jr.
Reference: J. Med. Chem., 50 (21), 5128-5134, 2007. (see link for full paper).
Authors: Bing Wang, Lance M. Westerhoff, and Kenneth M. Merz Jr.
Reference: J. Med. Chem., 50 (21), 5128-5134, 2007. (see link for full paper).
The role of quantum mechanics in structure-based drug design
Abstract: Herein we will focus on
the use of quantum mechanics (QM) in drug design (DD)
to solve disparate problems from scoring
protein–ligand poses to building QM QSAR
models. Through the variational principle of QM we
know that we can obtain a more accurate
representation of molecular systems than classical
models, and while this is not a matter of debate, it
still has not been shown that the expense of QM
approaches is offset by improved accuracy in DD
applications. Objectively validating the improved
applicability and performance of QM over
classical-based models in DD will be the focus of
research in the coming years along with research on
the conformational sampling problem as it relates to
protein–ligand complexes.
Authors: Kaushik Raha, Martin B. Peters, Bing Wang, Ning Yu, Andrew M. Wollacott, Lance M. Westerhoff, and Kenneth M. Merz Jr.
Reference: Drug Discovery Today. 2007, 12:17-18, 725-731. (see link for full paper).
Authors: Kaushik Raha, Martin B. Peters, Bing Wang, Ning Yu, Andrew M. Wollacott, Lance M. Westerhoff, and Kenneth M. Merz Jr.
Reference: Drug Discovery Today. 2007, 12:17-18, 725-731. (see link for full paper).